ReCor Medical Announces Positive Results in RADIANCE-HTN TRIO Study and Breakthrough Device Designation for Paradise(TM) Ultrasound Renal Denervation System
PALO ALTO, Calif., Dec. 10, 2020 -- (Healthcare Sales & Marketing Network) -- ReCor Medical, Inc. ("ReCor"), a wholly-owned subsidiary of Otsuka Medical Devices, announced today that its Paradise Ultrasound Renal Denervation System (the "P... Devices, Cardiology, FDA ReCor Medical, Otsuka Medical Devices, Renal Denervation, hypertension
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cardiology | Heart | Hypertension | Marketing | Medical Devices | Pharmaceuticals | Study | Ultrasound